These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36167282)

  • 1. Deep learning methods for molecular representation and property prediction.
    Li Z; Jiang M; Wang S; Zhang S
    Drug Discov Today; 2022 Dec; 27(12):103373. PubMed ID: 36167282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review.
    Gangwal A; Ansari A; Ahmad I; Azad AK; Wan Sulaiman WMA
    Comput Biol Med; 2024 Sep; 179():108734. PubMed ID: 38964243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CADD, AI and ML in drug discovery: A comprehensive review.
    Vemula D; Jayasurya P; Sushmitha V; Kumar YN; Bhandari V
    Eur J Pharm Sci; 2023 Feb; 181():106324. PubMed ID: 36347444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications.
    Sumathi S; Suganya K; Swathi K; Sudha B; Poornima A; Varghese CA; Aswathy R
    Curr Pharm Des; 2023 May; 29(13):1013-1025. PubMed ID: 37055908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FG-BERT: a generalized and self-supervised functional group-based molecular representation learning framework for properties prediction.
    Li B; Lin M; Chen T; Wang L
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37930026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Progress of Deep Learning in Drug Discovery.
    Wang F; Diao X; Chang S; Xu L
    Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.
    Jing Y; Bian Y; Hu Z; Wang L; Xie XQ
    AAPS J; 2018 Mar; 20(3):58. PubMed ID: 29603063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Drug Discovery with Deep Learning.
    Özçelik R; van Tilborg D; Jiménez-Luna J; Grisoni F
    Chembiochem; 2023 Jul; 24(13):e202200776. PubMed ID: 37014633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Deep Learning for Property-driven Drug Design.
    Born J; Manica M
    Curr Med Chem; 2021; 28(38):7862-7886. PubMed ID: 34325627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular property prediction: recent trends in the era of artificial intelligence.
    Shen J; Nicolaou CA
    Drug Discov Today Technol; 2019 Dec; 32-33():29-36. PubMed ID: 33386091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence: Deep learning in oncological radiomics and challenges of interpretability and data harmonization.
    Papadimitroulas P; Brocki L; Christopher Chung N; Marchadour W; Vermet F; Gaubert L; Eleftheriadis V; Plachouris D; Visvikis D; Kagadis GC; Hatt M
    Phys Med; 2021 Mar; 83():108-121. PubMed ID: 33765601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).
    Lee JW; Maria-Solano MA; Vu TNL; Yoon S; Choi S
    Biochem Soc Trans; 2022 Feb; 50(1):241-252. PubMed ID: 35076690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MG-BERT: leveraging unsupervised atomic representation learning for molecular property prediction.
    Zhang XC; Wu CK; Yang ZJ; Wu ZX; Yi JC; Hsieh CY; Hou TJ; Cao DS
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33951729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges.
    Thomas M; Boardman A; Garcia-Ortegon M; Yang H; de Graaf C; Bender A
    Methods Mol Biol; 2022; 2390():1-59. PubMed ID: 34731463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction.
    Huang DZ; Baber JC; Bahmanyar SS
    Expert Opin Drug Discov; 2021 Sep; 16(9):1045-1056. PubMed ID: 33739897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 18. Object recognition in medical images via anatomy-guided deep learning.
    Jin C; Udupa JK; Zhao L; Tong Y; Odhner D; Pednekar G; Nag S; Lewis S; Poole N; Mannikeri S; Govindasamy S; Singh A; Camaratta J; Owens S; Torigian DA
    Med Image Anal; 2022 Oct; 81():102527. PubMed ID: 35830745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Molecular Positron Emission Tomography Imaging Using Advanced Deep Learning Techniques.
    Zaidi H; El Naqa I
    Annu Rev Biomed Eng; 2021 Jul; 23():249-276. PubMed ID: 33797938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.